GeminIQ Website Logo

Viewing MBOT free

Subscribe for full history, 90+ metrics, screener, watchlist...

Microbot Medical Inc.

MBOT

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
344743302121
Assets Current
Assets Current
727780813331657788
Marketable Securities Current
646975732927244547
Restricted Cash And Cash Equivalents At Carrying V…
000000000000
Other Assets Current
----------1-
Deposits Assets Current
11----------
Accounts Receivable Net Current
00----------
Inventory Net
321---------
Prepaid Expense And Other Assets Current
111100011100
Assets Noncurrent
Restricted Cash And Cash Equivalents Noncurrent
000---------
Deposit Assets
--1---------
Deposits Assets Noncurrent
00----------
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
111100000000
Accounts Payable Trade Current
------0---0-
Assets
737882823331657789
Liabilities And Stockhold…
Accounts Payable Current
1111100000-0
Operating Lease Liability Current
000000000000
Liabilities Current
Liabilities Current
433332211141
Litigation Reserve Current
----------2-
Accrued Liabilities Current
323222211111
Liabilities Noncurrent
Operating Lease Liability Noncurrent
111100000000
Liabilities
444432311142
Common Stock Value
111100000000
Additional Paid In Capital Common Stock
182181181178127122949190888484
Stockholders Equity
Stockholders Equity
697478783029446657
Retained Earnings Accumulated Deficit
-113-108-104-101-97-94-91-88-84-82-80-76
Liabilities And Stockholders Equity
737882823331657789
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
12012012012012060606060606060
Common Stock Shares Issued
676767663835191716141212
Shares Outstanding
676767663835191716141212

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-15.21%-11.98%-20.74%---------
202514.23%5.69%3.66%17.31%-1.60%-28.53%11.79%-0.47%-15.09%-10.69%-29.39%-32.06%
202416.13%15.05%-1.08%-11.11%-9.09%-4.04%-2.00%114.00%84.00%56.60%68.55%47.17%
2023----1.92%-34.13%-31.73%-10.07%-0.72%-12.95%-24.35%-18.26%-6.09%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
18.56
22.59
23.33
27.53
12.06
16.19
2.37
3.64
5.32
5.92
2.09
5.64
Quick Ratio
17.63
21.73
22.97
27.34
12.00
16.08
2.24
3.20
4.85
5.41
2.05
5.50
Working Capital
68.29M
73.14M
76.40M
77.85M
30.16M
28.76M
3.36M
3.62M
5.80M
5.82M
4.14M
6.92M
Leverage & Debt
Debt to Equity
0.06
0.05
0.05
0.05
0.09
0.07
0.71
0.37
0.23
0.19
0.85
0.21
Interest Coverage TTM
-8.54
-8.77
-11.47
-21.63
-29.94
-44.92
-63.87
-60.02
-51.67
-53.26
-43.22
-39.33
Debt Ratio
0.06
0.05
0.05
0.04
0.08
0.06
0.41
0.27
0.19
0.16
0.46
0.17
Efficiency & Turnover
Asset Turnover TTM
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Days Sales Outstanding TTM
185.66
365.00
-
-
-
-
-
-
-
-
-
-
Receivables Turnover TTM
1.97
1.00
-
-
-
-
-
-
-
-
-
-
Per Share Metrics
Diluted EPS TTM
-0.24
-0.21
-0.29
-0.27
-0.35
-0.38
-0.73
-0.68
-0.70
-0.73
-1.05
-0.90
Free Cash Flow Per Share TTM
-0.27
-0.23
-0.29
-0.23
-0.27
-0.30
-0.57
-0.55
-0.53
-0.56
-0.84
-0.79
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-5,348.84%
-15,278.10%
-
-
-
-
-
-
-
-
-
-
Net Profit Margin TTM
-4,722.25%
-13,535.24%
-
-
-
-
-
-
-
-
-
-
Growth Metrics
Net Income Growth (1Y)
28.57%
21.75%
14.85%
16.64%
21.77%
13.79%
6.55%
5.87%
-10.08%
-20.06%
-18.44%
-24.56%
EPS Growth (1Y)
-30.15%
-43.64%
-60.76%
-60.05%
-50.45%
-48.55%
-30.53%
-24.75%
-44.29%
-54.43%
-41.94%
-54.19%
Valuation Metrics
P/E TTM
-8.02
-11.39
-6.97
-11.22
-7.24
-4.02
-1.53
-1.31
-1.45
-1.69
-1.56
-1.54
P/B TTM
1.90
2.18
1.18
1.88
3.03
1.62
4.96
3.85
2.50
2.80
3.72
2.21
P/S TTM
378.52
1,541.44
-
-
-
-
-
-
-
-
-
-
Market Cap
130.97M
161.85M
91.58M
146.69M
91.95M
46.94M
17.52M
14.66M
15.14M
17.29M
16.73M
16.27M
Enterprise Value
127.82M
158.19M
87.67M
139.93M
87.81M
43.72M
14.41M
14.13M
12.63M
16.13M
14.26M
14.94M
Calculated Values
Free Cash Flow TTM
-17.93M
-15.38M
-13.11M
-11.02M
-9.93M
-9.31M
-8.85M
-8.98M
-7.90M
-7.81M
-8.58M
-9.21M
Net Debt
-3.15M
-3.66M
-3.91M
-6.76M
-4.14M
-3.22M
-3.11M
-527.00K
-2.51M
-1.16M
-2.47M
-1.34M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2020-10-19Sale
Owner: Bornstein, Yoseph
Title: -
Shares: 4,881
Price/Share: $7.94
Value: $38,755.14
Shares Owned: 242,028
Relationship: Director
Ownership: Indirect
2020-10-12Sale
Owner: Bornstein, Yoseph
Title: -
Shares: 20,000
Price/Share: $7.84
Value: $156,800.00
Shares Owned: 246,909
Relationship: Director
Ownership: Indirect
2020-10-05Sale
Owner: Bornstein, Yoseph
Title: -
Shares: 20,000
Price/Share: $7.84
Value: $156,800.00
Shares Owned: 246,909
Relationship: Director
Ownership: Indirect
2020-08-17Sale
Owner: Bornstein, Yoseph
Title: -
Shares: 15,119
Price/Share: $11.04
Value: $166,913.76
Shares Owned: 286,909
Relationship: Director
Ownership: Indirect
2019-12-23Sale
Owner: Gadot, Harel
Title: Chairman, President and CEO
Shares: 40,000
Price/Share: $10.00
Value: $400,000.00
Shares Owned: 136,847
Relationship: Director,Officer
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
21.14%
Inst. Shares: 14,195,610
Shares Outstanding: 67,158,044
2025-12-31
24.68%
Inst. Shares: 11,301,976
Shares Outstanding: 45,790,362
2025-09-30
21.62%
Inst. Shares: 10,395,896
Shares Outstanding: 48,095,384
2025-06-30
12.01%
Inst. Shares: 4,383,908
Shares Outstanding: 36,488,014
2025-03-31
6.76%
Inst. Shares: 2,101,665
Shares Outstanding: 31,085,606

Microbot Medical Inc. (MBOT) — SEC Financial Statements & Analysis

Microbot Medical Inc. (MBOT) is a surgical & medical instruments & apparatus company, incorporated in DE. Microbot Medical Inc. trades on Nasdaq as: MBOT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Microbot Medical Inc. reported a Debt-to-Equity ratio of 0.06x, a Price-to-Sales (P/S) ratio of 378.52x (TTM), a Price-to-Book (P/B) ratio of 1.90x (TTM), at a market cap of $130.97M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
0.06x
P/S TTM
378.52x
P/B TTM
1.90x
Market Cap
$130.97M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Microbot Medical Inc. in?

Microbot Medical Inc. (MBOT) operates in the Surgical & Medical Instruments & Apparatus industry.

What is MBOT's market cap?

Microbot Medical Inc. (MBOT) has a market capitalization of $130.97M as of 2026-06-30.

What exchange does MBOT trade on?

Microbot Medical Inc. (MBOT) trades on the Nasdaq.

Where is Microbot Medical Inc. incorporated?

Microbot Medical Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.